EB RI Team at EB2026: Talks and On-Site Exchange

EB RI Managing Director Dr. Hana Cernecka, EB RI Biobank Manager Dr. Christina Guttmann-Gruber as well as EB RI Programm Leaders Dr. Josefina Pinon-Hofbauer and Dr. Ulrich Koller will be attending the EB2026 on site, actively contributing to the program with a series of scheduled talks.

At designated times, our members will be sharing insights and expertise on selected topics. Beyond the stage, we are excited to connect, exchange ideas, and discuss perspectives with fellow attendees.

Here are the details of our talks:

Wednesday, 21 January 2026 | 13:45 - 15:25
3rd Session: Basic Science for the Understanding of EB   
Oral abstract: The EB Cell Atlas: A Framework for Translational Drug Discovery | Christina Guttmann-Gruber

Thursday, 22 January 2026 | 08:30 - 10:15
5th Session: Preclinical studies Part 2  
• Patient-Derived Samples as a Prerequisite for Pre-Clinical Research | Christina Guttmann-Gruber
• Gene editing for type XVII collagen deficient JEB | Ulrich Koller
 

Dr. Hana Cernecka warmly invites conference attendees to meet the team in person: “We look forward to engaging conversations and new connections throughout the event.”